Back to results
US 2025/0026725 A1Published application
Hydrate crystal of 5-chloro-4-(3-chloro-4- methylphenyl)-1h-imidazole-2-carbonitrile
AssigneeIshihara Sangyo Kaisha, Ltd.
InventorsHiroshi Shikama, Koji Higuchi, Shogo Atsumi, Hiroto Shiota, Takayuki Imura
Life of this patent
Estimating the term…
Abstract
The present invention relates to a hydrate crystal of 5-chloro-4-(3-chloro-4-methylphenyl)-1H-imidazole-2-carbonitrile.
Claims20
A hydrate crystal of 5-chloro-4-(3-chloro-4-methylphenyl)-1H-imidazole-2-carbonitrile.
A method of producing a pharmaceutical, a quasi-drug, a veterinary drug or a cosmetic comprising:
- using a hydrate crystal of 5-chloro-4-(3-chloro-4-methylphenyl)-1H-imidazole-2-carbonitrile.
A method of producing an antimicrobial agent comprising:
- using a hydrate crystal of 5-chloro-4-(3-chloro-4-methylphenyl)-1H-imidazole-2-carbonitrile.
A method for ameliorating a symptom or a disease caused by a fungus or a bacterium, comprising
- administering to a subject in need thereof, an effective amount of a hydrate crystal of 5-chloro-4-(3-chloro-4-methylphenyl)-1H-imidazole-2-carbonitrile.
Dependencies are inferred from the claim text.